Synarc Inc
Industry / private company
Location:
Newark, CA,
United States (USA) (US)
ISNI: 0000000406021531
ROR: https://ror.org/03t95yr58
Show on Map:
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study (2016)
Edwards MH, Parsons C, Bruyere O, Dop FP, Chapurlat R, Roemer F, Guermazi A, et al.
Journal article
Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial (2015)
Engelke K, Fuerst T, Dardzinski B, Kornak J, Ather S, Genant HK, De Papp A
Journal article
The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study (2014)
Engelke K, Nagase S, Fuerst T, Small M, Kuwayama T, Deacon S, Eastell R, Genant HK
Journal article
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength (2014)
Cheung AM, Majumdar S, Brixen K, Chapurlat R, Fuerst T, Engelke K, Dardzinski B, et al.
Journal article
Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab (2014)
Keaveny TM, Mcclung MR, Genant HK, Zanchetta JR, Kendler D, Brown JP, Goemaere S, et al.
Journal article